Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: Beyond the homeostatic control of food intake

Psychoneuroendocrinology

Volumn 38, Issue 3, 2013, Pages 312-330

  Monteleone, Palmiero ^a,b   Maj, Mario ^b  

^a UNIVERSITY OF SALERNO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Anorexia nervosa; Appetite modulators; Bulimia nervosa; Energy balance; Reward

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ENDOCANNABINOID; GHRELIN; LEPTIN; OBESTATIN;

ANOREXIA; BRAIN REGION; COGNITION; DOPAMINERGIC ACTIVITY; EATING DISORDER; ENERGY BALANCE; FOOD INTAKE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STARVATION; WEIGHT REDUCTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; EATING; EATING DISORDERS; ENDOCANNABINOIDS; GHRELIN; HOMEOSTASIS; HUMANS; LEPTIN;

EID: 84875244668     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.10.021     Document Type: Review

References (229)

1. Abell T.L., Malagelada J.R., Brown M.L., Camilleri M., Go V.L.W., Aspiroz F., Callaway C.W., Kao P.C., Zinsmeister A.R., Huse D.M. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology 1987, 93:958-965.
2. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschop M.H., Gao X.B., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 2006, 116:3229-3239.
3. Alderdice J.T., Dinsmore W.W., Buchanan K.D., Adams C. Gastrointestinal hormones in anorexia nervosa. J. Psychiatr. Res. 1985, 19:207-213.
4. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., Katsuura G., Makino S., Fujino M.A., Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001, 74:143-147.
5. Ballauff A., Ziegler A., Emons G., Sturm G., Blum W.F., Remschmidt H., Hebebrand J. Serum leptin and gonadotropin levels in patients with anorexia nervosa during weight gain. Mol. Psychiatry 1999, 4:71-75.
6. Balligand J.L., Brichard S.M., Brichard V., Desager J.P., Lambert M. Hypoleptinemia in patients with anorexia nervosa, loss of circadian rhythm and unresponsiveness to short-term refeeding. Eur. J. Endocrinol. 1998, 138:415-420.
7. Baranowska B. Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa. Psychoneuroendocrinology 1990, 15:371-379.
8. Baranowska B., Radzikowska M., Wasilewska-Dziubinska E., Plonowski A., Roguski K. Neuropeptide Y, galanin and leptin release in obese women and in women with anorexia nervosa. Metabolism. 1997, 46:1384-1389.
9. Baranowska B., Radzikowska M., Wasilewska-Dziubinska E., Roguski K., Boroviec M. Disturbed release of gastrointestinal peptides in anorexia nervosa. Diabetes Obesity Metab. 2000, 2:99-103.
10. Bergh C., Sodersten P. Anorexia nervosa, self-starvation and the reward of stress. Nat. Med. 1996, 2:21-22.
11. Berrettini W.H., Kaye W.H., Sunderland T., May C., Gwirtsman H.E., Yellow A., Albright A. Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease. Neuropsychobiology 1988, 19:64-68.
12. Berridge K.C. Food reward, brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 1996, 20:1-25.
13. Berry E.M. Pilot Study of THC (2.5mg×2) in 9 ambulatory AN patients (abstract). The sixth nordic congress on eating disorders 2006, Aarhus, Denmark.
14. Blum K., Liu Y., Shriner R., Gold M.S. Reward circuitry dopaminergic activation regulates food and drug craving behavior. Curr. Pharm. Des. 2011, 17:1158-1167.
15. Blundell J.E., Goodson S., Halford J.C.G. Regulation of appetite, role of leptin in signalling systems for drive and satiety. Int. J. Obes. 2001, 25(Suppl. 1):529-534.
16. Brambilla F., Ferrari E., Petraglia F., Facchinetti G., Catalano M., Genazzani A.R. Peripheral opioid secretory pattern in anorexia nervosa. Psychiatr. Res. 1991, 39:115-127.
17. Brambilla F., Brunetta M., Peirone A., Perna G., Sacerdote P., Manfredi B. T-lymphocyte cholecystokinin-8 and β-endorphin concentrations in eating disorders. I. Anorexia nervosa. Psychiatr. Res. 1995, 29:43-50.
18. Brambilla F., Brunetta M., Draisci A., Peirone A., Perna G., Sacerdote P., Manfredi B., Panerai A. T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders, II Bulimia nervosa. Psychiatr. Res. 1995, 59:51-56.
19. Brambilla F., Monteleone P., Bortolotti F., Dalle Grave R., Todisco P., Favaro A., Santonastaso P., Ramacciotti C., Paoli R., Maj M. Persistent amenorrhoea in weight-recovered anorexics, psychological and biological aspects. Psychiatr. Res. 2003, 118:249-257.
20. Brandys M.K., Kas M.J., van Elburg A.A., Campbell I.C., Adan R.A. A meta-analysis of circulating BDNF concentrations in anorexia nervosa. World J. Biol. Psychiatry 2011, 12:444-454.
21. Brewerton T.D., Lydiard R.B., Laraia M.T., Shook J.E. CSF-β-endorphin and dynorphin in bulimia nervosa. Am. J. Psychiatry 1992, 149:1086-1090.
22. Brewerton T.D., Lesem M.D., Kennedy A., Garvey W.T. Reduced plasma leptin concentrations in bulimia nervosa. Psychoneuroendocrinology 2000, 25:649-658.
23. Bronsky J., Nedvidkova J., Krasnicanova H., Vesela M., Schmidtova J., Koutek J., Kellermayer R., Chada M., Kabelka Z., Hrdlicka M., Nevoral J., Prusa R. Changes of orexin A plasma levels in girls with anorexia nervosa during eight weeks of realimentation. Int. J. Eat. Disord. 2011, 44:547-552.
24. Carroll M.E., Stotz D.C., Kliner D.J., Meisch R.A. Self-administration of orally-delivered methohexital in rhesus monkeys with phencyclidine or pentobarbital histories, effects of food deprivation and satiation. Pharmacol. Biochem. Behav. 1984, 20:145-151.
25. Casper R.C., Pandy G.N., Jaspan J.B., Rubenstein A.H. Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls. Biol. Psychiatry 1988, 24:663-674.
26. Chan J.L., Mantzoros C.S. Role of leptin in energy-deprivation states, normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005, 366:74-85.
27. Chiodera P., Volpi R., Capretti L., Marchesi C., D'Amato L., De Ferri A., Bianconi L., Coiro V. Effect of estrogens or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa. Metabolism. 1991, 40:1226-1230.
28. Chiodera P., Volpi R., Marchesi C., Caffarra P., De Ferri A., Capretti L., Speroni G., D'Amato L., Coiro V. Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglycemia in normal weight bulimic women. Neuroendocrinology 1993, 57:907-911.
29. Cordeira J., Frank L., Sena-Esteves M., Pothos E., Rios M. Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J. Neurosci. 2010, 30:2533-2541.
30. Cota D., Marsicano G., Tschop M., Grübler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thöne-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C., Pasquali R., Lutz B., Stalla G.K., Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 2003, 112:423-431.
31. Cota D., Marsicano G., Lutz B., Stalla G.K., Pasquali R.P., Pagotto U. Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. Relat. Metab. Disord. 2003, 27:289-301.
32. Cowely M., Smart J., Rubinstein M., Cerdan M., Diano S., Horvath T., Cone R., Low M. Leptin activates anorexinergic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 6836:480-484.
33. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
34. Davis J.F., Choi D.L., Benoit S.C. Insulin, leptin and reward. Trends Endocrinol. Metab. 2010, 21:68-74.
35. Davis J.F., Choi D.L., Schurdak J.D., Fitzgerald M.F., Clegg D.J., Lipton J.W., Figlewicz D.P., Benoit S.C. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biol. Psychiatry 2011, 69:668-674.
36. de Rijke C.E., Hillebrand J.J., Verhagen L.A., Roeling T.A., Adan R.A. Hypothalamic neuropeptide expression following chronic food restriction in sedentary and wheel-running rats. J. Mol. Endocrinol. 2005, 35:381-390.
37. Delporte M.L., Brichard S.M., Hermans M.P., Beguin C., Lambert M. Hyperadiponectinaemia in anorexia nervosa. Clin. Endocrinol. 2003, 58:22-29.
38. Demitrack M.A., Lesem M.D., Listwak S.J., Brandt H.A., Jimerson D.C., Gold P.W. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. Am. J. Psychiatry 1990, 147:882-886.
39. Demitrack M.A., Kalogeras K.T., Altemus M., Pigott T.A., Listvwak S.J., Gold P.W. Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects. J. Clin. Endocrinol. Metab. 1992, 74:1277-1284.
40. Devlin M.J., Walsh B., Kraft J.G., Heymsfield S.B., Pi-Sunyer F.X., Dantzic S. Metabolic abnormalities in bulimia nervosa. Arch. Gen. Psychiatry 1990, 47:144-148.
41. Di Marzo V., Goparaju S.K., Wang L., Liu J., Bátkai S., Járai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
42. Diano S., Farr S.A., Benoit S.C., McNay E.C., da Silva I., Horvath B., Gaskin F.S., Nonaka N., Jaeger L.B., Banks W.A., Morley J.E., Pinto S., Sherwin R.S., Xu L., Yamada K.A., Sleeman M.W., Tschöp M.H., Horvath T.L. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 2006, 9:381-388.
43. Djurovic M., Pekic S., Petakov M., Damjanovic S., Doknic M., Dieguez C., Casanueva F.F., Popovic V. Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa. J. Endocrinol. Invest. 2004, 227:523-527.
44. Dolezalova R., Lacinova Z., Dolinkova M., Kleiblova P., Haluzikova D., Housa D., Papezova H., Haluzik M. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin. Endocrinol. 2007, 67:674-678.
45. Dostalova I., Kopsky V., Duskova J., Papezova H., Pacak K., Nedvidkova J. Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regul. Pept. 2005, 128:63-68.
46. Dostalova I., Smitka K., Papezova H., Kvasnickova H., Nedvidkova J. Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines. Physiol. Res. 2006, 56:587-594.
47. Dostalova I., Kunesova M., Duskova J., Papezova H., Nedvidkova J. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition 2006, 22:977-983.
48. Dostalova I., Kavalkova P., Haluzikova D., Lacinová Z., Mráz M., Papezová H., Haluzík M. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2008, 93:3627-3632.
49. Dostálová I., Sedlácková D., Papezová H., Nedvídková J., Haluzík M. Serum visfatin levels in patients with anorexia nervosa and bulimia nervosa. Physiol. Res. 2009, 58:903-907.
50. Dostálová I., Kaválková P., Papezová H., Domluvilová D., Zikán V., Haluzík M. Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. Nutr. Metab. 2010, 7:34.
51. Ehrlich S., Salbach-Andrae H., Eckart S., Merle J.V., Burghardt R., Pfeiffer E., Franke L., Uebelhack R., Lehmkuhl U., Hellweg R. Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. J. Psychiatr. Neurosci. 2009, 34:323-329.
52. Exner C., Hebebrand J., Remschmidt H., Wewetzer C., Ziegler A., Herpertz S., Schweiger U., Blum W.F., Preibisch G., Heldmaier G., Klingenspor M. Leptin suppresses semi-starvation induced hyperactivity in rats, implications for anorexia nervosa. Mol. Psychiatry 2000, 5:476-481.
53. Fantuzzi G., Faggioni R. Leptin in the regulation of immunity, inflammation, and haematopoiesis. J. Leukoc. Biol. 2000, 68:437-446.
54. Farooqi I.S., Bullmore E., Keogh J., Gillard J., O'Rahilly S., Fletcher P.C. Leptin regulates striatal regions and human eating behavior. Science 2007, 317:1355.
55. Fazeli P.K., Misra M., Goldstein M., Miller K.K., Klibanski A. Fibroblast Growth Factor-21 may mediate growth hormone resistance in anorexia nervosa. J. Clin. Endocrinol. Metab. 2010, 95:369-374.
56. Finlayson G., King N., Blundell J.E. Liking vs. wanting food, importance for human appetite control and weight regulation. Neurosci. Biobehav. Rev. 2007, 31:987-1002.
57. Fladung A.K., Grön G., Grammer K., Herrnberger B., Schilly E., Grasteit S., Wolf R.C., Walter H., von Wietersheim J. A neural signature of anorexia nervosa in the ventral striatal reward system. Am. J. Psychiatry 2010, 167:206-212.
58. Frank G.K., Kaye W.H., Altemus M., Greeno C.G. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype. Biol. Psychiatry 2000, 48:315-318.
59. Frank G.K., Kaye W.H., Sahu A., Fernstrom J., McConaha C. Could reduced cerebrospinal fluid (CSF) galanin contribute to restricted eating in anorexia nervosa?. Neuropsychopharmacology 2001, 24:706-709.
60. Frieling H., Albrecht H., Jedtberg S., Gozner A., Lenz B., Wilhelm J., Hillemacher T., de Zwaan M., Kornhuber J., Bleich S. Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders. Psychoneuroendocrinology 2009, 34:620-624.
61. Fujii S., Tamai H., Kumai M., Takaichi Y., Nakagawa T., Aoki T.T. Impaired glucagon secretion to insulin-induced hypoglycemia in anorexia nervosa. Acta Endocrinol. 1989, 120:610-615.
62. Fujimoto S., Inui A., Kiyota N., Seki W., Koide K., Takamiya S., Uemoto M., Nakajima Y., Baba S., Kasuga M. Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa. Biol. Psychiatry 1997, 41:1068-1070.
63. Fullerton D.T., Swift W.J., Getto C.J., Carlson I.H. Plasma immunoreactive beta-endorphin in bulimics. Psychol. Med. 1986, 16:56-63.
64. Galderisi S., Mucci A., Monteleone P., Sorrentino D., Piegari G., Maj M. Neurocognitive functioning in subjects with eating disorders, the influence of neuroactive steroids. Biol. Psychiatry 2003, 53:921-927.
65. Garg A. Commentary, the ongoing saga of obestatin, is it a hormone?. J. Clin. Endocrinol. Metab. 2007, 92:3396-3398.
66. Geiger B.M., Haburcak M., Avena N.M., Moyer M.C., Hoebel B.G., Pothos E.N. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 2009, 159:1193-1199.
67. Gelegen C., van den Heuvel J., Collier D.A., Campbell I.C., Oppelaar H., Hessel E., Kas M.J. Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain. Behav. 2008, 7:552-559.
68. Gendall K.A., Kaye W.H., Altemus M., McConaha C.W., La Via M.C. Leptin, neuropeptide Y, and peptide YY in long term recovered eating disorder patients. Biol. Psychiatry 1999, 46:292-299.
69. Geracioti T.D., Liddle R.A. Impaired cholecystokinin secretion in bulimia nervosa. New Engl. J. Med. 1988, 319:683-688.
70. Geracioti T.D., Liddle R.A., Altemus M., Demitrack M.A., Gold P.W. Regulation of appetite and cholecystokinin secretion in Anorexia Nervosa. Am. J. Psychiatry 1992, 149:958-961.
71. Gérard N., Pieters G., Goffin K., Bormans G., Van Laere K. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol. Psychiatry 2011, 70:777-784.
72. Germain N., Galusca B., Grouselle D., Frere D., Tolle V., Zizzari P., Lang F., Epelbaum J., Estour B. Ghrelin/obestatin ratio in two populations with low body weight, constitutional thinness and anorexia nervosa. Psychoneuroendocrinology 2009, 34:413-419.
73. Gerner R.H., Gwirtsman H.E. Abnormalities of the dexamethasone suppression test and urinary MHPG in anorexia nervosa. Am. J. Psychiatry 1981, 138:650-654.
74. Gerner R.H., Sharp S. Beta-endorphin immunoreactivity in normal, schizophrenic, depressed, manic, and anorexic subjects. Brain Res. 1982, 237:244-247.
75. Gerner R.H., Yamada T. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res. 1982, 238:298-302.
76. Gianotti L., Rolla M., Arvat E., Belliti D., Valetta M.R., Federghini M., Ghigo E., Muller E.E. Effects of somatostatin infusion on the somatotropic responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. Biol. Psychiatry 1999, 45:334-339.
77. Gniuli D., Liverani E., Capristo E., Greco A.V., Mingrone G. Blunted glucose metabolism in anorexia nervosa. Metabolism 2001, 50:876-881.
78. Gold P.W., Kaye W., Robertson G.L., Ebert M. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in women with anorexia nervosa. New Engl. J. Med. 1983, 308:1117-1123.
79. Gourcerol G., St-Pierre D.H., Taché Y. Lack of obestatin effects on food intake, should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul. Pept. 2007, 141:1-7.
80. Gross H., Ebert M.H., Faden V.B., Goldberg S.C., Kaye W.H., Caine E.D., Hawks R., Zinberg N. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa before and during weight recovery. Am. J. Clin. Psychopharmacol. 1983, 3:165-171.
81. Gwirtsman H.E., Roy P., Yager R.H. Neuroendocrine abnormalities in bulimia. Am. J. Psychiatry 1983, 140:559-563.
82. Haas V., Onur S., Paul T., Nutzinger D.O., Bosy-Westphal A., Hauer M. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am. J. Clin. Nutr. 2005, 81:889-896.
83. Harada T., Nakahara T., Yasuhara D., Kojima S., Sagiyama K., Amitani H., Laviano A., Naruo T., Inui A. Obestatin, acylghrelin, and des-acylghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol. Psychiatry 2008, 63:245-247.
84. Harty R.F., Pearson P.H., Solomon T.E., McGuigan J.E. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul. Pept. 1991, 36:141-150.
85. Heatherton T.F., Baumeister R.F. Binge eating as escape from self-awareness. Psychol. Bull. 1991, 110:86-108.
86. Hebebrand J., Blum W.F., Barth N., Coners H., Englaro P., Juul A., Ziegler A., Warnke A., Rascher W., Remschmidt H. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol. Psychiatry 1997, 2:330-334.
87. Hebebrand J., Exner C., Hebebrand K., Holtkamp C., Casper R.C., Remschmidt H., Herpertz-Dahlmann B., Klingenspor M. Hyperactivity in patients with anorexia nervosa and in semistarved rats, evidence for a pivotal role of hypoleptinemia. Physiol. Behav. 2003, 79:25-37.
88. Hillebrand J.J.G., De Wied D., Adan R.A.H. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 2002, 23:2283-2306.
89. Holsen L.M., Lawson E.A., Blum J., Ko E., Makris N., Fazeli P.K., Klibanski A., Goldstein J.M. Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa. J. Psychiatr. Neurosci. 2012, 37. 10.1503/cjs.110156.
90. Holtkamp K., Hebebrand J., Mika C., Grzella I., Heer M., Heussen N., Herpertz-Dahlmann B. The effect of therapeutically induced weight gain on plasma leptin levels in patients with anorexia nervosa. J. Psychiatr. Res. 2003, 37:165-169.
91. Holtkamp K., Herpertz-Dahlmann B., Mika C., Heer M., Heussen N., Fichter M., Herpertz S., Senf W., Blum W.F., Schweiger U., Warnke A., Ballauff A., Remschmidt H., Hebebrand J. Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2003, 88:5169-5174.
92. Holtkamp K., Hebebrand J., Mika C., Heer M., Heussen N., Herpertz-Dahlmann B. High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa. Psychoneuroendocrinoogy 2004, 29:791-797.
93. Holtkamp K., Herpertz-Dahlmann B., Hebebrand K., Mika C., Kratzsch J., Hebebrand J. Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biol. Psychiatry 2006, 60:311-313.
94. Hotta M., Shibasaki T., Masuda A., Imaki T., Demura H., Ling N., Shizume K. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactivity CRH in anorexia nervosa patients. J. Clin. Endocrinol. Metab. 1986, 62:319-324.
95. Hotta M., Ohwada R., Katakami H., Shibasaki T., Hizuka N., Takano K. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J. Clin. Endocrinol. Metab. 2004, 89:5707-5712.
96. Housova J., Anderlova K., Krizova J., Haluzikova D., Kremen J., Kumstyrova T., Papezova H., Haluzik M. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J. Clin. Endocrinol. Metab. 2005, 90:1366-1370.
97. Invitti C., Brunanti A., Pasqualinotto L., Dubini A., Bendinelli P., Maroni P., Cavagnini F. Plasma galanin concentrations in obese, normal weight and anorectic women. Int. J. Obesity 1995, 19:347-349.
98. Ishibashi K., Berman S.M., Paz-Filho G., Lee B., Robertson C., Mandelkern M.A., Wong M.L., Licinio J., London E.D. Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement. Mol. Psychiatry 2012, 17:352-353.
99. Janas-Kozik M., Krupka-Matuszczyk I., Malinowska-Kolodziej I., Lewin-Kowalik J. Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa. Regul. Pept. 2007, 140:43-46.
100. Janas-Kozik M., Stachowicz M., Krupka-Matuszczyk I., Szymszal J., Krysta K., Janas A., Rybakowski J.K. Plasma levels of leptin and orexin A in the restrictive type of anorexia nervosa. Regul. Pept. 2011, 168:5-9.
101. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict. Biol. 2007, 12:6-16.
102. Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict. Biol. 2008, 13:358-363.
103. Jimerson D.C., Mantzoros C., Wolfe B.E., Metzger E.D. Decreased serum leptin in bulimia nervosa. J. Clin. Endocrinol. Metab. 2000, 85:4511-4514.
104. Johnson C., Larson R. Bulimia, an analysis of moods and behavior. Psychosom. Med. 1982, 44:341-351.
105. Karczewska-Kupczewska M., Straczkowski M., Adamska A., Nikołajuk A., Otziomek E., Górska M., Kowalska I. Insulin sensitivity, metabolic flexibility, and serum adiponectin concentration in women with anorexia nervosa. Metabolism. 2010, 59:473-477.
106. Kaye W.H., Pickar D., Naber D., Ebert M.H. Cerebrospinal fluid opioid activity in anorexia nervosa. Am. J. Psychiatry 1982, 139:643-645.
107. Kaye W.H., Berrettini W.H., Gwirtsman H.E., Chretien M., Gold P.W., George D.T., Jimerson D.C., Ebert M.H. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including β-endorphin) in anorexia nervosa. Life Sci. 1987, 41:2147-2155.
108. Kaye W.H., Gwirtsman H.E., George D.T., Ebert M.H., Jimerson D.C., Tomai T.P., Chrousos G.P., Gold P.W. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depressin. J. Clin. Endocrinol. Metab. 1987, 64:203-208.
109. Kaye W.H., Rubinow D., Gwirtsman H.E., George D.T., Jimerson D.C., Gold P.W. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic-pituitary-adrenal cortical axis. Psychoneuroendocrinology 1988, 13:265-272.
110. Kaye W.H., Berrettini W., Gwirtsman H., George D.T. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch. Gen. Psychiatry 1990, 47:548-556.
111. Kaye W.H. Neuropeptide abnormalities in anorexia nervosa. Psychiatr. Res. 1996, 62:65-74.
112. Kaye W.H., Fudge J.L., Paulus M. New insight into symptoms and neurocircuit function of anorexia nervosa. Nat. Rev. Neurosci. 2009, 10:573-584.
113. Keating C., Tilbrook A.J., Rossell S.L., Enticott P.G., Fitzgerald P.B. Reward processing in anorexia nervosa. Neuropsychologia 2012, 50:567-575.
114. Keel P.K., Wolfe B.E., Liddle R.A., De Young K.P., Jimerson D.C. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. Arch. Gen. Psychiatry 2007, 64:1058-1066.
115. Kern A., Albarran-Zeckler R., Walsh H.E., Smith R.G. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 2012, 73:317-332.
116. Kernie S.G., Liebl D.J., Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 2000, 19:1290-1300.
117. Kinzig K.P., Coughlin J.W., Redgrave G.W., Moran T.H., Guarda A.S. Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1441-E1446.
118. Kirkham T.C., Williams C.M., Fezza F., Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation, stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 2002, 136:550-557.
119. Kobayashi N., Tamai H., Uehara S., Komaki G., Mori K., Matsubayashi S., Nakagawa T. Pancreatic abnormalities in patients with eating disorders. Psychosom. Med. 1988, 50:607-614.
120. Kojima S., Nakahara T., Nagai N., Muranaga T., Tanaka M., Yasuhara D., Masuda A., Date Y., Ueno H., Nakazato M., Navuo T. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin. Endocrinol. 2005, 62:74-78.
121. Kowalska I., Karczewska-Kupczewska M., Straczkowski M. Adipocytokines, gut hormones and growth factors in anorexia nervosa. Clin. Chim. Acta 2011, 412:1702-1711.
122. Kristenssson E., Sundqvist M., Astin M., Kjerling M., Mattsson H., Dornonville de la Cour C., Håkanson R., Lindström E. Acute psychological stress raises plasma ghrelin in the rat. Regul. Pept. 2006, 134:114-117.
123. Krizova J., Papezova H., Haluzikova D., Kremen J., Kumstyrova T., Papezova H., Haluzik M. Soluble leptin receptor levels in patients with anorexia nervosa. Endocr. Res. 2002, 28:199-205.
124. Krügel U., Schraft T., Kittner H., Kiess W., Illes P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur. J. Pharmacol. 2003, 482:185-187.
125. Lasègue C. De l'anorexie hystèrique. Arch. Gèn. Mèd. 1873, 1:384-403.
126. Lawson E.A., Donoho D.A., Blum J.I., Meenaghan E.M., Misra M., Herzog D.B., Sluss P.M., Miller K.K., Klibanski A. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J. Clin. Psychiatry 2011, 72:1546-1551.
127. Lawson E.A., Holsen L.M., Santin M., Meenaghan E., Eddy K.T., Becker A.E., Herzog D.B., Goldstein J.M., Klibanski A. Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J. Clin. Endocrinol. Metab. 2012, 97:1898-1908.
128. Lesem M.D., Berrettini W.H., Kaye W.H., Jimerson D.C. Measurement of CSF dynorphin A 1-8 immunoreactivity n anorexia nervosa and normal weight bulimia. Biol. Psychiatry 1991, 29:244-252.
129. Lesem M.D., Kaye W.H., Bissette G., Jimerson D.C., Nemeroff C.F. Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa. Biol. Psychiatry 1994, 35:48-53.
130. Lob S., Pickel J., Bidlingmaier M., Schaaf L., Backmund H., Gerlinghoff M., Stalla G.K. Serum leptin monitoring in anorectic patients during refeeding therapy. Exp. Clin. Endocrinol. Diabetes 2003, 111:278-282.
131. Lutter M., Nestler E.J. Homeostatic and hedonic signals interact in the regulation of food intake. J. Nutr. 2009, 139:629-632.
132. Lydiard R.B., Brewerton T.D., Fossey M.D., Laraia M.T., Stuart G., Beinfeld M.C., Ballenger J.C. CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. Am. J. Psychiatry 1993, 150:1099-1101.
133. Malik S., McGlone F., Bedrossian D., Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell. Metab. 2008, 7:400-409.
134. Mantzoros C., Flier J.S., Lesem M.D., Brewerton T.D., Jimerson D.C. Cerebrospinal fluid leptin in anorexia nervosa, correlation with nutritional status and potential role in resistance to weight gain. J. Clin. Endocrinol. Metab. 1997, 82:1845-1851.
135. Marais L., Stein D.J., Daniels W.M. Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats. Metab. Brain. Dis. 2009, 24:587-597.
136. Mercader J.M., Ribasès M., Gratacòs M., González J.R., Bayés M., de Cid R., Badía A., Fernández-Aranda F., Estivill X. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav. 2007, 6:706-716.
137. Merle J.V., Haas V., Burghardt R., Döhler N., Schneider N., Lehmkuhl U., Ehrlich S. Agouti-related protein in patients with acute and weight-restored anorexia nervosa. Psychol. Med. 2011, 41:2183-2192.
138. Misra M., Miller K.K., Bjornson J., Hackman A., Aggarwal A., Chung J., Ott M., Herzog D.B., Johnson M.L., Klibanski A. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effect on bone metabolism. J. Clin. Endocrinol. Metab. 2003, 88:5615-5623.
139. Misra M., Miller K.K., Almazan C., Ramaswamy K., Aggarwal A., Herzog D.B., Neubauer G., Breu J., Klibanski A. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J. Clin. Endocrinol. Metab. 2004, 89:3486-3495.
140. Misra M., Miller K., Herzog D., Ramaswamy K., Aggarwal A., Almazan C., Neubauer G., Breu J., Klibanski A. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J. Clin. Endocrinol. Metab. 2004, 89:1605-1612.
141. Misra M., Miller K.K., Tsai P., Gallagher K., Lin A., Lee N., Herzog D.B., Klibanski A. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J. Clin. Endocrinol. Metab. 2006, 91:1027-1033.
142. Modan-Moses D., Stain D., Pariente C., Yaroslavsky A., Ram A., Faigin M., Loewenthal R., Yissachar E., Hemi R., Kanety H. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J. Clin. Endocrinol. Metab. 2007, 92:1843-1847.
143. Monteleone P., Di Lieto A., Tortorella A., Longobardi N., Maj M. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder, relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatr. Res. 2000, 94:121-129.
144. Monteleone P., Bortolotti F., Fabrazzo M., La Rocca A., Fuschino A., Maj M. Plasma leptin response to acute fasting and refeeding in untreated women with bulimia nervosa. J. Clin. Endocrinol. Metab. 2000, 85:2499-2503.
145. Monteleone P., Fabrazzo M., Tortorella A., Fuschino A., Maj M. Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum. Mol. Psychiatry 2002, 7:641-646.
146. Monteleone P., Martiadis V., Colurcio B., Maj M. Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosom. Med. 2002, 64:874-879.
147. Monteleone P., Fabrazzo M., Martiadis V., Fuschino A., Serritella C., Milici N., Maj M. Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder. J. Clin. Endocrinol. Metab. 2003, 88:5387-5391.
148. Monteleone P., Tortorella A., Martiadis V., Serritella C., Fuschino A., Maj M. Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom. Med. 2004, 66:744-748.
149. Monteleone P., Fabrazzo M., Tortorella A., Martiadis V., Serritella C., Maj M. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa. Psychoneuroendocrinology 2005, 30:243-250.
150. Monteleone P., Martiadis V., Rigamonti A.E., Fabrazzo M., Giordani C., Muller E.E., Maj M. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol. Psychiatry 2005, 57:926-931.
151. Monteleone P., Fabrazzo M., Martiadis V., Serritella C., Pannuto M., Maj M. Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder, relationships to co-morbid depression, psychopathology and hormonal variables. Psychol. Med. 2005, 35:897-905.
152. Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 2005, 30:1216-1221.
153. Monteleone P., Castaldo E., Maj M. Neuroendocrine dysregulation of food intake in eating disorders. Regul. Pept. 2008, 149:39-50.
154. Monteleone P., Serritella C., Martiadis V., Maj M. Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol. Psychiatry 2008, 64:1005-1008.
155. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J. Clin. Endocrinol. Metab. 2008, 93:4418-4421.
156. Monteleone P., Serritella C., Scognamiglio P., Maj M. Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology 2009, 35:284-288.
157. Monteleone P., Bifulco M., Di Filippo C., Gazzerro P., Canestrelli B., Monteleone F., Proto M.C., Di Genio M., Grimaldi C., Maj M. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa, evidence for synergistic effects. Genes Brain Behav. 2009, 8:728-732.
158. Monteleone P., Piscitelli F., Scognamiglio P., Monteleone A.M., Canestrelli B., Di Marzo V., Maj M. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. J. Clin. Endocrinol. Metab. 2012, 97:917-E924.
159. Monteleone P., Tortorella A., Scognamiglio P., Serino I., Monteleone A.M., Maj M. The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa, a pilot study. Neuropsychobiology 2012, 66:230-236.
160. Moriya J., Takimoto Y., Yoshiuchi K., Shimosawa T., Akabayashi A. Plasma agouti-related protein levels in women with anorexia nervosa. Psychoneuroendocrinology 2006, 31:1057-1061.
161. Moschos S., Chan J.L., Mantzoros C.S. Leptin and reproduction, a review. Fertil. Steril. 2002, 77:433-444.
162. Muller T.D., Reichwald K., Bronner G., Kirschner J., Nguyen T.T., Scherag A., Herzog W., Herpertz-Dahlmann B., Lichtner P., Meitinger T., Platzer M., Schäfer H., Hebebrand J., Hinney A. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adol. Psychiatry Ment. Health 2008, 2:33-39.
163. Murphy K.G., Bloom S.R. Gut hormones and the regulation of energy homeostasis. Nature 2006, 444:854-859.
164. Nakagawa T., Tsuchida A., Itakura Y., Nonomura T., Ono M., Hirota F., Inoue T., Nakayama C., Taiji M., Naguchi H. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000, 49:436-444.
165. Nakahara T., Kojima S., Tanaka M., Yasuhara D., Harada T., Sagiyama K., Muranaga T., Nagai N., Nakazato M., Nozoe S., Naruo T., Inui A. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J. Psychiatr. Res. 2007, 41:814-820.
166. Nakahara T., Harada T., Yasuhara D., Shimada N., Amitani H., Sakoguchi T., Kamiji M.M., Asakawa A., Inui A. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol. Psychiatry 2008, 64:252-255.
167. Nakai Y., Hosoda H., Nin K., Ooya C., Hayashi H., Akamizu T., Kangawa K. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur. J. Endocrinol. 2003, 149:R1-R3.
168. Nakazato M., Hashimoto K., Shimizu E., Kumakiri C., Koizumi H., Okamura N., Mitsumori M., Komatsu N., Iyo M. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol. Psychiatry 2003, 54:485-490.
169. Nakazato M., Hashimoto K., Shiina A., Koizumi H., Mitsumoti M., Imai M., Shimizu E., Iyo M. No changes in serum ghrelin levels in female patients with bulimia nervosa. Prog. NeuroPsychopharmacol. Biol. Psychiatry 2004, 28:1181-1184.
170. Nakazato M., Hashimoto K., Yoshimura K., Hashimoto T., Shimizu E., Iyo M. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Prog. NeuroPsychopharmacol. Biol. Psychiatry 2006, 30:1117-1121.
171. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci. 2006, 26:398-405.
172. Nedvidkova J., Krykorkova I., Bartak V., Papezova H., Gold P.W., Alesci S., Pacak K. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2003, 88:1678-1682.
173. Nemeroff C.B., Bissette G., Widerlow E., Beckman H., Gerner R., Manberg P.J., Lindstrom L., Prange A.J., Gattaz W.F. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa, bulimia and premenstrual syndrome. J. Neuropsychiatr. 1989, 1:16-20.
174. Nogueira J.P., Maraninchi M., Lorec A.M., Corroller A.B., Nicolay A., Gaudart J., Portugal H., Barone R., Vialettes B., Valéro R. Specific adipocytokines profiles in patients with hyperactive and/or binge/purge form of anorexia nervosa. Eur. J. Clin. Nutr. 2010, 64:840-844.
175. Numan S., Seroogy K.B. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons. A double-label in situ hybridization study. J. Comp. Neurol. 1999, 403:295-308.
176. Otani M., Takimoto Y., Moriya J., Yoshiuchi K., Akabayashi A. Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa. Biopsychosoc. Med. 2008, 2:10.
177. Otani M., Takimoto Y., Moriya J., Yoshiuchi K., Akabayashi A. Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study. Biopsychosoc. Med. 2011, 5:7.
178. Otto B., Tschop M., Fruhauf E., Heldwein W., Fichter M., Otto C., Cuntz U. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology 2005, 30:577-581.
179. Otto B., Cuntz U., Otto C., Heldwein W., Riepl R.L., Tschop M.H. Peptide YY release in anorectic patients after liquid meal. Appetite 2007, 48:301-314.
180. Pannacciulli N., Vettor R., Milan G., Granzotto M., Catucci A., Federspil G. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J. Clin. Endocrinol. Metab. 2003, 88:1748-1752.
181. Pearce J.M. Richard Morton, origins of anorexia nervosa. Eur. Neurol. 2004, 52:191-192.
182. Perello M., Sakata I., Birnbaum S., Chuang J.C., Osborne-Lawrence S., Rovinsky S.A., Woloszyn J., Yanagisawa M., Lutter M., Zigman J.M. Ghrelin increases the rewarding value of high-fat diet in an orexin dependent manner. Biol. Psychiatry 2010, 67:880-886.
183. Pfaffly J., Michaelides M., Wang G.J., Pessin J.E., Volkow N.D., Thanos P.K. Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice. Synapse 2010, 64:503-510.
184. Pfluger P.T., Kirchner H., Günnel S., Schrott B., Perez-Tilve D., Fu S., Benoit S.C., Horvath T., Joost H.G., Wortley K.E., Sleeman M.W., Tschöp M.H. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:610-618.
185. Phillipp E., Pirke K.M., Kellner M.B., Krieg J.C. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci. 1991, 48:2443-2450.
186. Pirke K.M., Philipp E., Friess E., Kellner B., Wilkens T., Krieg J.C., Fichter M.M. The role of gastrointestinal hormone secretion in eating disorders. Adv. Biosciences 1993, 60:75-79.
187. Prince A.C., Brooks S.J., Stahl D., Treasure J. Systematic review and meta-analysis of the baseline concentrations and physiological responses of gut hormones to food in eating disorders. Am. J. Clin. Nutr. 2009, 89:755-765.
188. Redgrave G.W., Bakker A., Bello N.T., Caffo B.S., Coughlin J.W., Guarda A.S., McEntee J.E., Pekar J.J., Reinblatt S.P., Verduzco G., Moran T.H. Differential brain activation in anorexia nervosa to Fat and Thin words during a Stroop task. Neuroreport 2008, 19:1181-1185.
189. Rouach V., Bloch M., Rosenberg N., Gilad S., Limor R., Stern N., Greenman Y. The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat. Psychoneuroendocrinology 2007, 32:693-702.
190. Schreiber W., Schweiger U., Werner D., Brunner G., Tuschl R.J., Laessle R.G., Krieg J.C., Fichter M.M., Pirke K.M. Circadian pattern of large neutral aminoacids, glucose, insulin, and food intake in anorexia nervosa and bulimia nervosa. Metabolism. 1991, 40:503-507.
191. Schroeder M., Eberlein C., de Zwaan M., Kornhuber J., Bleich S., Frieling H. Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior. Psychoneuroendocrinology 2012, (Epub ahead of print).
192. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
193. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
194. Sedláčková D., Kopečková J., PapeŽová H., Vybíral S., Kvasničková H., Hill M., Nedvídková J. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol. Res. 2011, 60:165-173.
195. Seoane L.M., Al-Massadi O., Pazos Y., Pagotto U., Casanueva F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J. Endocrinol. Invest. 2006, 29:RC13-RC15.
196. Shalev U., Yap J., Shaham Y. Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J. Neurosci. 2001, 21:RC129.
197. Skibicka K.P., Hansson C., Egecioglu E., Dickson S.L. Role of ghrelin in food reward, impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict. Biol. 2011, 10.1111/j.1369-1600.2010.00294.x.
198. Solinas M., Justinova Z., Goldberg S.R., Tanda G. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nuclear accumbens shell in rats. J. Neurochem. 2006, 98:408-419.
199. Soriano-Guillen L., Barrios V., Campos-Barros A., Argente J. Ghrelin levels in obesity and anorexia nervosa, effect of weight reduction or recuperation. J. Pediatr. 2004, 144:36-42.
200. Stock S., Leichner P., Wong A.C., Ghatei M.A., Kieffer T.J., Bloom S.R., Chanoine J.P. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J. Clin. Endocrinol. Metab. 2005, 90:2161-2168.
201. Stoving R.K., Chen J.W., Glintborg D., Brixen K., Flyvbjerg A., Hørder K., Frystyk J. Bioactive insulin-like growth factor (IGF) I and IGF-I binding protein-1 in anorexia nervosa. J. Clin. Endocrinol. Metab. 2007, 92:2323-2329.
202. Støving R.K., Andries A., Brixen K., Flyvbjerg A., Hørder K., Frystyk J. Leptin, ghrelin, and endocannabinoids, potential therapeutic targets in anorexia nervosa. J. Psychiatr. Res. 2009, 43:671-679.
203. Sun Y., Asnicar M., Saha P.K., Chan L., Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006, 3:379-386.
204. Tagami T., Satoh N., Usui T., Yamada K., Shimatsu A., Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J. Clin. Endocrinol. Metab. 2004, 89:1833-1837.
205. Tamai H., Takemura J., Kobayashi N., Matsubayashi S., Matsukura S., Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism. 1993, 45:581-584.
206. Tanaka M., Naruo T., Yasuhara D., Tatebe Y., Nagai N., Shiiya T., Nakazato M., Matsukura S., Nozoe S. Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 2003, 28:829-835.
207. Tanaka M., Narau T., Nagai N., Kuroki N., Shiiya T., Nakazato M., Matsukura S., Nozoe S. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J. Psychiatr. Res. 2003, 37:17-22.
208. Tanaka M., Tatebe Y., Nakahara T., Yasuhara D., Sagiyama K., Muranaga T., Ueno H., Nakazato M., Nozoe S., Naruo T. Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clin. Endocrinol. 2003, 59:574-579.
209. Tanaka M., Nakahara T., Kojima S., Nakano T., Muranaga T., Nagai N., Ueno H., Nakazato M., Nozoe S., Naruo T. Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa. Regul. Pept. 2004, 122:163-168.
210. Tang D., Han J.E., Rangel A., Dagher A. Administration of ghrelin increases willingness to pay for food, a neuroeconomics approach to obesity. Keystone Symposia on Molecular and Cellular Biology, Obesity 2011.
211. Tepper R., Weixman A., Apter A., Tyano S., Beyth Y. Elevated plasma immunoreactive β-endorphin in anorexia nervosa. Clin. Neuropharmacol. 1992, 15:387-391.
212. Tomasik P.J., Sztefko K., Starzyk J., Rogatko I., Szafran Z. Entero-insular axis in children with anorexia nervosa. Psychoneuroendocrinology 2005, 30:364-372.
213. Troisi A., Di Lorenzo G., Lega I., Tesauro M., Bertoli A., Leo R., Intorno M., Pecchioli C., Rizza S., Turriziani M., Lauro R., Siracusano A. Plasma ghrelin in anorexia, bulimia, and binge-eating disorder, relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 2005, 81:259-266.
214. Tsuchida A., Nonomura T., Ono-Kishino M., Nakagawa T., Taiji M., Noguchi H. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1286-1293.
215. Uehara T., Omori I., Nakamura K., Suda M., Hosoda Y., Minegishi T., Mikuni M., Kangawa K. Plasma des-acyl and acyl ghrelin in patients with eating disorders. Eat. Weight Disord. 2005, 10:264-266.
216. Uhe A.M., Szmukler G.I., Collier G.R., Hansky J., O'Dea K., Young G.P. Potential regulators of feeding behavior in anorexia nervosa. Am. J. Clin. Nutr. 1992, 55:28-32.
217. Verhagen L.A., Luijendijk M.C., Adan R.A. Leptin reduces hyperactivity in an animal model for anorexia nervosa via the ventral tegmental area. Eur. Neuropsychopharmacol. 2011, 21:274-281.
218. Verty A.N., Evetts M.J., Crouch G.J., McGregor I.S., Stefanidis A., Oldfield B.J. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology 2011, 36:1349-1358.
219. Waller D.A., Kiser R.S., Hardy B.W., Fuchs I., Feigenbaum L.P., Uauy R. Eating behavior and plasma beta-endorphin in bulimia. Am. J. Clin. Nutr. 1986, 44:20-23.
220. Walsh B.T. Psychobiology of eating behavior in bulimia. Int. J. Neuropsychopharmacol. 2002, 5:S40-S43.
221. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S. Brain dopamine and obesity. Lancet 2001, 357:354-357.
222. Weingarten H.P., Hendler R., Rodin J. Metabolism and endocrine secretion in response to a test meal in normal-weight bulimic women. Psychosom. Med. 1988, 50:273-285.
223. Williams C.M., Kirkham T.C. Observational analysis of feeding induced by Delta-9-THC and anandamide. Physiol. Behav. 2002, 76:241-250.
224. Wise R.A. Brain reward circuitry, insights from unsensed incentives. Neuron 2002, 36:229-240.
225. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
226. Zheng H., Patterson L.M., Berthoud H.R. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J. Neurosci. 2007, 27:11075-11082.
227. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., Seeley R.J., Lowell B.B., Elmquist J.K. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 2005, 115:3564-3572.
228. Ziora K.T., Oswiecimska J.M., Swietochowska E., Ostrowska Z., Stojewska M., Gorczyca P., Rojewska K., Ziora-Jakutowicz K., Szczepanska M., Ziora D. Assessment of serum levels resistin in girls with anorexia nervosa, Part I. Relationship between resistin and body mass index. Neuroendocrinol. Lett. 2011, 32:691-696.
229. Ziora K., OŚwiecimska J., Swietochowska E., Ziora D., Stojewska M., Suwała A., Ostrowska Z., Gorczyca P., Klimacka-Nawrot E., Lukas W., Błońska-Fajfrowska B. Assessment of serum visfatin levels in girls with anorexia nervosa. Clin. Endocrinol. 2012, 76:514-519.